JPWO2023010073A5 - - Google Patents
Info
- Publication number
- JPWO2023010073A5 JPWO2023010073A5 JP2024505066A JP2024505066A JPWO2023010073A5 JP WO2023010073 A5 JPWO2023010073 A5 JP WO2023010073A5 JP 2024505066 A JP2024505066 A JP 2024505066A JP 2024505066 A JP2024505066 A JP 2024505066A JP WO2023010073 A5 JPWO2023010073 A5 JP WO2023010073A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- engineered
- receptor
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163226559P | 2021-07-28 | 2021-07-28 | |
| US63/226,559 | 2021-07-28 | ||
| PCT/US2022/074251 WO2023010073A1 (en) | 2021-07-28 | 2022-07-28 | Compositions and methods for improving t cell persistence and function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527997A JP2024527997A (ja) | 2024-07-26 |
| JPWO2023010073A5 true JPWO2023010073A5 (enExample) | 2025-08-04 |
Family
ID=85087331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505066A Pending JP2024527997A (ja) | 2021-07-28 | 2022-07-28 | Ｔ細胞持続性及び機能を改善するための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240327826A1 (enExample) |
| EP (1) | EP4376858A4 (enExample) |
| JP (1) | JP2024527997A (enExample) |
| CN (1) | CN117813102A (enExample) |
| WO (1) | WO2023010073A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024173916A1 (en) * | 2023-02-17 | 2024-08-22 | Dana-Farber Cancer Institute, Inc. | Compositions and methods of preventing t cell exhaustion |
| CN118345080B (zh) * | 2024-06-17 | 2024-09-24 | 江苏柯菲平医药股份有限公司 | 一种抗耗竭t细胞及其制备方法、应用 |
| CN119120385B (zh) * | 2024-11-14 | 2025-03-14 | 四川大学华西医院 | 一种具有长效抑瘤效果的嵌合抗原受体t细胞及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3701039A4 (en) * | 2017-10-27 | 2021-11-17 | The Trustees of The University of Pennsylvania | IDENTIFICATION OF EPIGENETIC AND TRANSCRIPT TARGETS TO PREVENT AND REVERSE T-LYMPHOCYTE DEPLETION |
| MX2020006015A (es) * | 2017-12-15 | 2020-10-12 | Univ Leland Stanford Junior | Composiciones y procedimientos para inhibir el agotamiento de celulas t. |
| CN118325839A (zh) * | 2018-03-27 | 2024-07-12 | 宾夕法尼亚大学董事会 | 具有增强功能的修饰的免疫细胞及其筛选方法 |
| CN110904045A (zh) * | 2018-09-17 | 2020-03-24 | 中国科学院动物研究所 | 经修饰的t细胞、其制备方法及用途 |
| US20220354889A1 (en) * | 2019-03-26 | 2022-11-10 | The Trustees Of The University Of Pennsylvania | Dnmt3a knockout car t cells for adoptive immunotherapy |
| US20220226380A1 (en) * | 2019-04-24 | 2022-07-21 | St. Jude Children's Research Hospital, Inc. | Gene knock-outs to improve t cell function |
-
2022
- 2022-07-28 WO PCT/US2022/074251 patent/WO2023010073A1/en not_active Ceased
- 2022-07-28 US US18/580,472 patent/US20240327826A1/en active Pending
- 2022-07-28 JP JP2024505066A patent/JP2024527997A/ja active Pending
- 2022-07-28 CN CN202280052739.XA patent/CN117813102A/zh active Pending
- 2022-07-28 EP EP22850516.0A patent/EP4376858A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12241053B2 (en) | Modulation of novel immune checkpoint targets | |
| US11186825B2 (en) | Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1 | |
| EP3368689B1 (en) | Composition for modulating immune responses by use of immune cell gene signature | |
| US11180730B2 (en) | Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3 | |
| JP2022547570A (ja) | 操作済みのアデノ随伴ウイルスキャプシド | |
| JP2020518256A5 (enExample) | ||
| WO2018204764A1 (en) | Identification and targeted modulation of gene signaling networks | |
| Huang et al. | Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS | |
| US20210113674A1 (en) | Compositions and methods for multiplexed tumor vaccination with endogenous gene activation | |
| AU2019384547B2 (en) | Compositions and methods for increasing fetal hemoglobin and treating sickle cell disease | |
| US12195723B2 (en) | Engineered antigen presenting cells and uses thereof | |
| JP2023138660A5 (enExample) | ||
| CN117716026A (zh) | 具有氧化应激抗性的间充质干细胞、其制备方法及用途 | |
| CN110885799A (zh) | 一种基于腺病毒的基因编辑方法 | |
| Long et al. | Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury | |
| JPWO2023010073A5 (enExample) | ||
| CN110964750A (zh) | 携带基因元件组合的嵌合抗原受体细胞文库、制备和筛选方法及用途 | |
| JP2024544587A (ja) | 異常メチル化の超高感度検出のための断片コンセンサス法 | |
| JP2024515113A (ja) | 重篤な疾患を処置するためのｂ細胞ベースのタンパク質工場の操作 | |
| JPWO2021136263A5 (enExample) | ||
| CN115087455A (zh) | 用于治疗或预防克罗恩病的组合物和方法 | |
| Ye et al. | Identify splenic IRF7 as nanotherapy target for tele-conditioning myocardial reperfusion injury | |
| US20250059585A1 (en) | Methods of removing embedding agents from embedded samples | |
| Wess et al. | Immuno-Oncology—The Translational Runway for Gene Therapy: Gene Therapeutics to Address Multiple Immune Targets | |
| CN121160628A (zh) | 一种制备通用型t细胞的新方法 |